Evidence map›Paper›PMID 22333747›Full record

SynthesisAIDS (London, England)2012

Social and structural factors associated with HIV disease progression among illicit drug users: a systematic review.

Michael-John S Milloy, Brandon D L Marshall, Thomas Kerr, Jane Buxton, Tim Rhodes, Julio Montaner, Evan Wood

Open access · greenAbstract readEditorialSystematic Review
In one paragraph

Synthesis in AIDS (London, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Michael-John S Milloy
Brandon D L Marshall
Thomas Kerr
Jane Buxton
Tim Rhodes
Julio Montaner
Evan Wood
St. Paul's Hospital · CAUniversity of British Columbia · CAAIDS Vancouver · CALondon School of Hygiene & Tropical Medicine · GB

Funding

Social and structural context of HIV/STI risk among FSWsR01DA028648 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI GOLDENBERG, SHIRA MIRIAM, KRUSI, ANDREA · 2010 to 2024
$6.9M
Impacts of universal access to HIV/AIDS care among HIV+ injection drug usersR01DA021525 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI MILLOY, M-J · 2007 to 2016
$5.8M
Seek and Treat for Optimal Outcomes and Prevention in HIV & AIDS in IDUDP1DA026182 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MONTANER, JULIO SERGIO GONZALEZ · 2008 to 2013
$3.9M
CIHR MOP-79297CIHR RAA-79918NIDA NIH HHS 1DP1DA026182-01NIDA NIH HHS R01 DA021525NIDA NIH HHS R01DA021525NIDA NIH HHS R01 DA028648PEPFAR
6 · The paper itself

Abstract

objectiveTo systematically review factors associated with HIV disease progression among illicit drug users, focusing on exposures exogenous to individuals that likely shape access and adherence to HIV treatment.

designA systematic review of peer-reviewed English-language studies among HIV-seropositive illicit drug users with at least one of these endpoint of interest: a diagnosis of AIDS; death; changes/differences in CD4 cell counts; or changes/differences in plasma HIV-1 RNA levels.

methodsArticles were included if they reported factors associated with an outcome of interest among a group of illicit drug users. Studies were identified, screened and selected using systematic methods.

resultsOf 2668 studies matching the search criteria, 58 (2%) met the inclusion criteria, all but one from North America or western Europe. Overall, 41 (71%) studies contained significant individual-level clinical characteristics or behaviors (e.g. illicit drug use) associated with disease progression. Fifteen studies (26%) identified significant social, physical, economic or policy-level exposures, including incarceration, housing status or lack of legal income.

conclusionAlthough past studies demonstrate important environmental exposures that appear to shape access to care and subsequent disease progression, the limited literature to examine these factors demonstrates the need for future research to consider risk environment characteristics and the role they may play in shaping health outcomes from HIV infection among drug users through determining access and adherence to evidence-based care.

Indexed as

Social EnvironmentAcquired Immunodeficiency SyndromeAdultAgedAntiretroviral Therapy, Highly ActiveDisease ProgressionDrug UsersFemaleHIV InfectionsHumansMaleMiddle AgedPatient Acceptance of Health CareRisk FactorsSubstance-Related DisordersTreatment Outcome

Identifiers

PMID22333747
PMCPMC3955099
OpenAlexW1985449809

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.